Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06833957Recruiting

Preparing for Maternal GBS Vaccine Trials in Africa

Role: collaborator

NCT03350048Completed

Evaluation of Host Biomarker-based Point-of-care Tests for Targeted Screening for Active TB

Role: collaborator

NCT04232618Unknown

Point-of-care Triage Test for Active Tuberculosis

Role: collaborator

All 3 trials loaded